Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
AxoGen, Inc.

AxoGen, Inc. (AXGN) Stock Overview

Explore AxoGen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AXGN●NASDAQ
HealthcareMedical - Devices
$50.64
$0.62(1.24%)
U.S. Market opens in 15h 51m

AxoGen, Inc. (AXGN)

Meyka AI Score

Z

Key Financials

Market Cap3B
P/E Ratio-76.39
EPS (TTM)$0.38
ROE-0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$57.64
3 Months$63.27
1 Year Target$53.82

AXGN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of AxoGen, Inc. (NASDAQ: AXGN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, AxoGen, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AXGN on the NASDAQ shows an RSI of 68.96, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $53.82 for the NASDAQ listing.

Key metrics behind AxoGen, Inc.'s NASDAQ-traded stock include a P/E ratio of -76.39 and a market capitalization of 3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AXGN on the NASDAQ.

Price Performance (NASDAQ: AXGN)

1-Day Change
1.24%
5-Day Change
0.72%
1-Month Change
40.16%
3-Month Change
9.07%
6-Month Change
20.40%
Year-to-Date (YTD) Change
54.72%
1-Year Change
111.00%
3-Year Change
902.77%
5-Year Change
277.91%
All-Time (Max) Change
1166.00%

Contact Information

https://www.axogeninc.com
386 462 6800
13631 Progress Boulevard, Alachua, FL, 32615

Company Facts

6,220 Employees
IPO DateDec 17, 1986
CountryUS
Actively Trading

Frequently Asked Questions